ES2111589T3 - Metodos y reactivos para la deteccion de la hepatitis c. - Google Patents

Metodos y reactivos para la deteccion de la hepatitis c.

Info

Publication number
ES2111589T3
ES2111589T3 ES92114115T ES92114115T ES2111589T3 ES 2111589 T3 ES2111589 T3 ES 2111589T3 ES 92114115 T ES92114115 T ES 92114115T ES 92114115 T ES92114115 T ES 92114115T ES 2111589 T3 ES2111589 T3 ES 2111589T3
Authority
ES
Spain
Prior art keywords
hepatitis
methods
reagents
detection
amplify
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92114115T
Other languages
English (en)
Inventor
Robert M Resnick
Karen K Y Young
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27115393&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2111589(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of ES2111589T3 publication Critical patent/ES2111589T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Paints Or Removers (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA INVENCION PROPORCIONA REACTIVOS, METODOS Y APARATOS PARA AMPLIFICAR Y DETECTAR ACIDOS NUCLEICOS DE PROTOTIPO EE.UU, JAPON Y HCV-C. SE PUEDEN UTILIZAR CARGAS DE OLIGONUCLEOTIDOS PARA AMPLIFICAR Y DETECTAR ACIDOS NUCLEICOS DEL VIRUS DE HEPATITIS C EN UN PROCESO QUE INCLUYE LA TRANSCRIPCION INVERSA DEL ARN GENOMICO VIRAL PARA CREAR CADN Y LA AMPLIFICACION POSTERIOR DEL CADN MEDIANTE LA REACCION EN CADENA DE POLIMERASA. SE PUEDEN UTILIZAR SONDAS DE OLIGONUCLEOTIDO PARA DETECTAR LA PRESENCIA DE ADN AMPLIFICADO MEDIANTE HIBRIDIZACION.
ES92114115T 1991-08-27 1992-08-19 Metodos y reactivos para la deteccion de la hepatitis c. Expired - Lifetime ES2111589T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75130591A 1991-08-27 1991-08-27
US91884492A 1992-07-21 1992-07-21

Publications (1)

Publication Number Publication Date
ES2111589T3 true ES2111589T3 (es) 1998-03-16

Family

ID=27115393

Family Applications (2)

Application Number Title Priority Date Filing Date
ES97106534T Expired - Lifetime ES2198514T3 (es) 1991-08-27 1992-08-19 Cebadores y sondas para la deteccion de la hepatitis c.
ES92114115T Expired - Lifetime ES2111589T3 (es) 1991-08-27 1992-08-19 Metodos y reactivos para la deteccion de la hepatitis c.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES97106534T Expired - Lifetime ES2198514T3 (es) 1991-08-27 1992-08-19 Cebadores y sondas para la deteccion de la hepatitis c.

Country Status (17)

Country Link
US (2) US5527669A (es)
EP (2) EP0529493B1 (es)
JP (2) JP3790274B2 (es)
KR (1) KR100280758B1 (es)
CN (2) CN1047630C (es)
AT (2) ATE241704T1 (es)
AU (1) AU665952B2 (es)
CA (1) CA2076793C (es)
DE (2) DE69223562T2 (es)
DK (2) DK0529493T3 (es)
ES (2) ES2198514T3 (es)
FI (1) FI108731B (es)
GR (1) GR3026312T3 (es)
IL (1) IL102896A (es)
NO (1) NO311730B1 (es)
NZ (1) NZ244071A (es)
PT (1) PT787807E (es)

Families Citing this family (101)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639594A (en) * 1990-02-16 1997-06-17 United Biomedical, Inc. Linear and branched peptides effective in diagnosing and detecting non-A, non-B hepatitis
US5582968A (en) * 1990-02-16 1996-12-10 United Biomedical, Inc. Branched hybrid and cluster peptides effective in diagnosing and detecting non-A, non-B hepatitis
EP0967279B1 (en) * 1992-03-02 2008-01-02 Novartis Vaccines and Diagnostics S.r.l. Helicobacter pylori cytotoxin useful for vaccines and diagnostics
US7141244B1 (en) * 1992-03-02 2006-11-28 Chiron Srl Helicobacter pylori proteins useful for vaccines and diagnostics
AU5141993A (en) * 1992-09-28 1994-04-26 Chiron Corporation Methods and compositions for controlling translation of hcv proteins
ES2133529T3 (es) * 1992-11-27 1999-09-16 Innogenetics Nv Procedimiento para tipificar aislamientos de hcv.
US7258977B1 (en) 1992-11-27 2007-08-21 Innogenetics N.V. Process for typing of HCV isolates
ES2232815T5 (es) * 1993-05-10 2009-06-15 Novartis Vaccines And Diagnostics, Inc. Metodos de tipado del virus de la hepatitis c y reactivos para usar en los mismos.
ATE205259T1 (de) * 1993-07-01 2001-09-15 Hoffmann La Roche Reagenz und verfahren für reverse transkription bei hoher temperatur, verbunden mit einer polymerase-kettenreaktion
US6156495A (en) * 1994-02-14 2000-12-05 Abbott Laboratories Hepatitis GB virus recombinant proteins and uses thereof
US6720166B2 (en) 1994-02-14 2004-04-13 Abbott Laboratories Non-a, non-b, non-c, non-c, non-d, non-e hepatitis reagents and methods for their use
US5981172A (en) * 1994-02-14 1999-11-09 Abbott Laboratories Non-A, non-B, non-C, non-D, non-E Hepatitis reagents and methods for their use
US6586568B1 (en) 1994-02-14 2003-07-01 Abbott Laboratories Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use
US6558898B1 (en) 1994-02-14 2003-05-06 Abbott Laboratories Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use
US6451578B1 (en) 1994-02-14 2002-09-17 Abbott Laboratories Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use
US5843450A (en) * 1994-02-14 1998-12-01 Abbott Laboratories Hepatitis GB Virus synthetic peptides and uses thereof
US6051374A (en) * 1994-02-14 2000-04-18 Abbott Laboratories Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use
DE69529219T2 (de) * 1994-07-01 2003-11-06 Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville Helicobacter proteine und impstoffe
US5955318A (en) * 1995-08-14 1999-09-21 Abbott Laboratories Reagents and methods useful for controlling the translation of hepatitis GBV proteins
US5807670A (en) * 1995-08-14 1998-09-15 Abbott Laboratories Detection of hepatitis GB virus genotypes
US6127116A (en) * 1995-08-29 2000-10-03 Washington University Functional DNA clone for hepatitis C virus (HCV) and uses thereof
US7235394B1 (en) 1995-08-29 2007-06-26 Washington University Functional DNA clone for hepatitis C virus (HCV) and uses thereof
US5837442A (en) * 1995-11-29 1998-11-17 Roche Molecular Systems, Inc. Oligonucleotide primers for amplifying HCV nucleic acid
GB2324093A (en) * 1996-01-04 1998-10-14 Rican Limited Helicobacter pylori bacterioferritin
US5759795A (en) * 1996-03-08 1998-06-02 Schering Corporation Assay for determining inhibitors of ATPase
IT1284847B1 (it) * 1996-06-07 1998-05-22 Sorin Biomedica Diagnostics Sp Procedimento per la rivelazione di acidi nucleici specifici di hcv
US5989873A (en) * 1996-09-24 1999-11-23 Vinayagamoorthy; Thuraiayah Method of detecting gene expression and/or of preventing such expression in cells
CU22642A1 (es) * 1996-12-12 2000-12-22 Ct Ingenieria Genetica Biotech Secuencia de adnc derivadas del genoma del virus de la hepatitis c y su uso
US7049428B1 (en) * 1998-03-04 2006-05-23 Washington University HCV variants
US7338759B1 (en) 1997-03-04 2008-03-04 Washington University HCV variants
US5849800A (en) * 1997-03-28 1998-12-15 The Penn State Research Foundation Use of amantadine for treatment of Hepatitis C
US6277571B1 (en) * 1997-10-03 2001-08-21 Virginia Commonwealth University Intellectual Property Foundation Sequential consensus region-directed amplification of known and novel members of gene families
WO1999023250A2 (de) 1997-11-04 1999-05-14 Roche Diagnostics Gmbh Spezifisches und sensitives nukleinsäurenachweisverfahren
DE19832050C2 (de) * 1998-07-16 2002-10-10 Biotest Pharma Gmbh Verfahren zum Nachweis von Hepatitis B- bzw. Hepatitis C-Virusgenomen in Plasmaproben und spezifische Primer
CA2245039A1 (en) * 1998-08-13 2000-02-13 Vito Scalia Primer-specific and mispair extension assay for identifying gene variation
US6300069B1 (en) * 1999-05-03 2001-10-09 Qiagen Gmbh Generation and amplification of nucleic acids from ribonucleic acids
WO2001036442A1 (en) * 1999-11-17 2001-05-25 Jiuping Ji Simultaneous detection of hbv, hcv and hiv in plasma samples using a multiplex capture assay
KR20020063123A (ko) * 2001-01-26 2002-08-01 (주)네오딘 알티 피시알에 의한 ｃ형 간염바이러스 검출을 위한 키트및 그 검출방법
US6586584B2 (en) 2001-01-29 2003-07-01 Becton, Dickinson And Company Sequences and methods for detection of Hepatitis C virus
US7226739B2 (en) 2001-03-02 2007-06-05 Isis Pharmaceuticals, Inc Methods for rapid detection and identification of bioagents in epidemiological and forensic investigations
US20030027135A1 (en) 2001-03-02 2003-02-06 Ecker David J. Method for rapid detection and identification of bioagents
US7666588B2 (en) 2001-03-02 2010-02-23 Ibis Biosciences, Inc. Methods for rapid forensic analysis of mitochondrial DNA and characterization of mitochondrial DNA heteroplasmy
US7718354B2 (en) 2001-03-02 2010-05-18 Ibis Biosciences, Inc. Methods for rapid identification of pathogens in humans and animals
US20040121309A1 (en) 2002-12-06 2004-06-24 Ecker David J. Methods for rapid detection and identification of bioagents in blood, bodily fluids, and bodily tissues
WO2004060278A2 (en) 2002-12-06 2004-07-22 Isis Pharmaceuticals, Inc. Methods for rapid identification of pathogens in humans and animals
WO2002090572A2 (en) * 2001-05-09 2002-11-14 Third Wave Technologies, Inc. Nucleic acid detection in pooled samples
US8073627B2 (en) * 2001-06-26 2011-12-06 Ibis Biosciences, Inc. System for indentification of pathogens
US7217510B2 (en) 2001-06-26 2007-05-15 Isis Pharmaceuticals, Inc. Methods for providing bacterial bioagent characterizing information
US7196183B2 (en) 2001-08-31 2007-03-27 Innogenetics N.V. Hepatitis C virus genotype, and its use as prophylactic, therapeutic and diagnostic agent
WO2003018054A1 (en) * 2001-08-31 2003-03-06 Chiron Srl. Helicobacter pylori vaccination
US6946245B2 (en) 2001-12-04 2005-09-20 Quest Diagnostics Investments Incorporated Oligonucleotides and methods for detecting hepatitis C viral nucleic acids
GB0200526D0 (en) * 2002-01-11 2002-02-27 Science And Technology The Methods
US20040024193A1 (en) * 2002-07-26 2004-02-05 Williams Gregg T. Method of detecting and quantifying hepatitis C virus
DE60330877D1 (de) 2002-07-26 2010-02-25 Abbott Lab Verfahren zum nachweis und zur quantifizierung von hepatitis-c-virus
WO2004094986A2 (en) * 2003-04-16 2004-11-04 Handylab, Inc. System and method for electrochemical detection of biological compounds
US8046171B2 (en) 2003-04-18 2011-10-25 Ibis Biosciences, Inc. Methods and apparatus for genetic evaluation
US8057993B2 (en) 2003-04-26 2011-11-15 Ibis Biosciences, Inc. Methods for identification of coronaviruses
US8158354B2 (en) 2003-05-13 2012-04-17 Ibis Biosciences, Inc. Methods for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture
US7964343B2 (en) 2003-05-13 2011-06-21 Ibis Biosciences, Inc. Method for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture
US7947450B2 (en) * 2003-07-10 2011-05-24 Universite Libre De Bruxelles Device, kit and method for pulsing biological samples with an agent and stabilising the sample so pulsed
JP4472634B2 (ja) * 2003-07-10 2010-06-02 ユニヴェルシテ リブル ドゥ ブリュッセル 生物学的試料を試剤でパルスし、こうしてパルスされた試料を安定化するための装置、キット及び方法
ES2596753T3 (es) 2003-08-29 2017-01-11 Fujirebio Europe N.V. Nuevo clado del virus de la hepatitis C y secuencias prototipo del mismo
US8097416B2 (en) 2003-09-11 2012-01-17 Ibis Biosciences, Inc. Methods for identification of sepsis-causing bacteria
US8546082B2 (en) 2003-09-11 2013-10-01 Ibis Biosciences, Inc. Methods for identification of sepsis-causing bacteria
US8242254B2 (en) 2003-09-11 2012-08-14 Ibis Biosciences, Inc. Compositions for use in identification of bacteria
TW201245229A (en) * 2003-10-14 2012-11-16 Hoffmann La Roche Macrocyclic carboxylic acids and acylsulfonamides as inhibitors of HCV replication
US8163895B2 (en) 2003-12-05 2012-04-24 Ibis Biosciences, Inc. Compositions for use in identification of orthopoxviruses
JP5138230B2 (ja) 2004-01-07 2013-02-06 サード・ウェーブ・テクノロジーズ・インク Ｃ型肝炎ウイルスの遺伝子型の決定方法
US7666592B2 (en) 2004-02-18 2010-02-23 Ibis Biosciences, Inc. Methods for concurrent identification and quantification of an unknown bioagent
US8119336B2 (en) 2004-03-03 2012-02-21 Ibis Biosciences, Inc. Compositions for use in identification of alphaviruses
ES2641832T3 (es) 2004-05-24 2017-11-14 Ibis Biosciences, Inc. Espectrometría de masas con filtración de iones selectiva por establecimiento de umbrales digitales
US20050266411A1 (en) 2004-05-25 2005-12-01 Hofstadler Steven A Methods for rapid forensic analysis of mitochondrial DNA
US7811753B2 (en) 2004-07-14 2010-10-12 Ibis Biosciences, Inc. Methods for repairing degraded DNA
US20060068396A1 (en) * 2004-09-24 2006-03-30 Kaohsiung Medical University Method for biochip detecting limited cells
US20060205040A1 (en) 2005-03-03 2006-09-14 Rangarajan Sampath Compositions for use in identification of adventitious viruses
US8084207B2 (en) 2005-03-03 2011-12-27 Ibis Bioscience, Inc. Compositions for use in identification of papillomavirus
US7919242B2 (en) 2005-06-30 2011-04-05 Roche Molecular Systems, Inc. Light emission modifiers and their uses in nucleic acid detection, amplification and analysis
EP1904655A2 (en) 2005-07-21 2008-04-02 Isis Pharmaceuticals, Inc. Methods for rapid identification and quantitation of nucleic acid variants
US20090050492A1 (en) * 2005-08-02 2009-02-26 Board Of Trustees Of Michigan State University Nanoporous silicon-based electrochemical nucleic acid biosensor
RU2329303C2 (ru) * 2006-08-02 2008-07-20 Государственное учреждение Научно-исследовательский институт вирусологии им. Д.И. Ивановского Российской академии медицинских наук Моноклональное антитело, иммунореактивное с белком нуклеокапсида (кор) вируса гепатита с-4g5, способ диагностики вгс-инфекции и комбинация моноклональных антител для его осуществления
AU2007353877B2 (en) 2006-09-14 2012-07-19 Ibis Biosciences, Inc. Targeted whole genome amplification method for identification of pathogens
JP5680304B2 (ja) 2007-02-23 2015-03-04 アイビス バイオサイエンシズ インコーポレイティッド 迅速な法医学的ｄｎａ分析法
US20100291544A1 (en) * 2007-05-25 2010-11-18 Ibis Biosciences, Inc. Compositions for use in identification of strains of hepatitis c virus
US9598724B2 (en) 2007-06-01 2017-03-21 Ibis Biosciences, Inc. Methods and compositions for multiple displacement amplification of nucleic acids
EP2349549B1 (en) 2008-09-16 2012-07-18 Ibis Biosciences, Inc. Mixing cartridges, mixing stations, and related kits, and system
US8534447B2 (en) 2008-09-16 2013-09-17 Ibis Biosciences, Inc. Microplate handling systems and related computer program products and methods
WO2010033627A2 (en) 2008-09-16 2010-03-25 Ibis Biosciences, Inc. Sample processing units, systems, and related methods
NZ594155A (en) 2009-01-21 2013-02-22 Vertex Pharma Methods for amplifying hepatitis c virus nucleic acids
EP2396803A4 (en) 2009-02-12 2016-10-26 Ibis Biosciences Inc IONIZATION PROBE ASSEMBLIES
US8950604B2 (en) 2009-07-17 2015-02-10 Ibis Biosciences, Inc. Lift and mount apparatus
EP2454000A4 (en) 2009-07-17 2016-08-10 Ibis Biosciences Inc SYSTEMS FOR IDENTIFYING BIOLOGICAL SUBSTANCES
EP2957641B1 (en) 2009-10-15 2017-05-17 Ibis Biosciences, Inc. Multiple displacement amplification
EP2707496A1 (en) 2011-05-11 2014-03-19 Diagon Kft. Procedure for rapid determination of viruses using nucleic acid-based molecular diagnostics, and a kit for this purpose
US9422601B2 (en) 2011-12-15 2016-08-23 Samsung Electronics Co., Ltd. Method of determining a ratio of RNA species in a sample
ES2659747T3 (es) 2012-10-18 2018-03-19 F. Hoffmann-La Roche Ag Ensayo de doble sonda para la detección de poblaciones heterogéneas de amplicón
EP2722398B1 (en) 2012-10-18 2017-07-12 F. Hoffmann-La Roche AG Dual probe assay for the detection of HCV
CN105483283B (zh) * 2014-10-11 2019-01-18 上海仁度生物科技有限公司 丙型肝炎病毒hcv实时荧光核酸恒温扩增检测试剂盒
EP3469102B1 (en) 2016-06-10 2023-01-25 Roche Diagnostics GmbH Compositions and methods for detection of hepatitis c virus genotype 3
CN108018376B (zh) * 2016-10-31 2020-11-03 深圳华大因源医药科技有限公司 一种用于丙肝病毒分型和耐药位点检测的探针和方法
ES3035799T3 (en) * 2017-10-03 2025-09-09 Abbott Molecular Inc Assay for detecting hepatitis c virus (hcv)
GB201819726D0 (en) * 2018-12-03 2019-01-16 Diagnostics For The Real World Ltd HCV detection

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683195A (en) * 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4965188A (en) * 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
WO1991009944A2 (en) * 1989-12-22 1991-07-11 F.Hoffmann-La Roche Ag High temperature reverse transcriptases
BR8807310A (pt) * 1987-11-18 1990-03-13 Chiron Corp Polinucleotidio,polinucleotidio recombinante,vetor recombinante,celula hospedeira,sistema de expressao recombinante,celula transformada,polipeptidio,hcv,preparacao de polipeptidio,polipeptidio de hcv,polipeptidio purificado,polipeptidio recombinante,polipeptidio de fusao,anticorpo monoclonal,preparacao purificada de anticorpos policlonais,particula,sonda de polinucleotidio,kit anticorpo para epetopo de hcv,metodo para producao de polipeptidio,metodo para deteccao de acidos nucleicos de hcv,imunoensaio para detectar antigeno de hcv,imunoensaio para detectar anticorpos dirigidos contra antigeno de hcv,vacina para tratamento de infeccao de hcv,celula,celula infectada com hcv,metodo para producao de anticorpos para hcv e metodo para isolar cdna derivado do genoma de um agente infeccioso nao identificado
HU225068B1 (en) * 1989-03-17 2006-05-29 Chiron Corp Process for producing diagnostics and vaccine of nanbh
JP2656996B2 (ja) * 1989-05-18 1997-09-24 カイロン コーポレイション Ｎａｎｂｖの診断用薬
DE4023458A1 (de) * 1989-08-31 1991-03-07 Kali Chemie Ag Neue hochalkalische proteasen
JP3156200B2 (ja) * 1989-09-15 2001-04-16 国立予防衛生研究所長 新規のｈｃｖ分離株
CA2032381C (en) * 1989-12-18 2006-02-21 Peter E. Highfield Viral agent
EP0461863A1 (en) * 1990-06-12 1991-12-18 Immuno Japan Inc. Oligonucleotide primers, and their application for high-fidelity detection of non-A, non-B hepatitis virus
EP0464287A1 (en) * 1990-06-25 1992-01-08 The Research Foundation for Microbial Diseases of Osaka University Non-A, non-B hepatitis virus genomic cDNA and antigen polypeptide
EP0468657A3 (en) * 1990-07-09 1992-02-05 Tonen Corporation Non-a non b hepatitis-specific antigen and its use in hepatitus diagnosis
EP0469348B1 (en) * 1990-07-11 1997-03-12 SHIONOGI SEIYAKU KABUSHIKI KAISHA trading under the name of SHIONOGI & CO. LTD. cDNA sequence and detection of hepatits C virus
ATE154646T1 (de) * 1990-08-10 1997-07-15 Chiron Corp Nanbv diagnostik: für die untersuchung auf hepatitis c verwendbare polynukleotide
EP1227323B2 (en) * 1990-08-25 2011-01-19 Bioprocess Pty Ltd Non-A, non-B hepatitis virus antigen, and diagnostic methods
CA2055149A1 (en) * 1990-11-08 1992-05-09 Hiroaki Okamoto Non-a, non-b hepatitis virus related antigen, antibody, detection systems, polynucleotides and polypeptides

Also Published As

Publication number Publication date
CA2076793C (en) 2006-11-21
EP0787807B1 (en) 2003-05-28
NO311730B1 (no) 2002-01-14
JPH0686700A (ja) 1994-03-29
CN1047630C (zh) 1999-12-22
FI108731B (fi) 2002-03-15
IL102896A (en) 1997-11-20
EP0787807A2 (en) 1997-08-06
EP0529493A3 (en) 1993-07-28
KR930004479A (en) 1993-03-22
US5580718A (en) 1996-12-03
EP0787807A3 (en) 1998-04-01
HK1027868A1 (en) 2001-01-23
FI923840A0 (fi) 1992-08-27
NZ244071A (en) 1995-01-27
NO923341L (no) 1993-03-01
ATE241704T1 (de) 2003-06-15
DE69223562D1 (de) 1998-01-29
FI923840L (fi) 1993-02-28
CA2076793A1 (en) 1993-02-28
DK0529493T3 (da) 1998-08-24
DE69233083T2 (de) 2003-12-18
IL102896A0 (en) 1993-01-31
CN1134666C (zh) 2004-01-14
US5527669A (en) 1996-06-18
DE69233083D1 (de) 2003-07-03
EP0529493B1 (en) 1997-12-17
ES2198514T3 (es) 2004-02-01
AU665952B2 (en) 1996-01-25
AU2121992A (en) 1993-03-04
JP4164098B2 (ja) 2008-10-08
JP3790274B2 (ja) 2006-06-28
PT787807E (pt) 2003-08-29
CN1259670A (zh) 2000-07-12
NO923341D0 (no) 1992-08-26
KR100280758B1 (ko) 2001-04-02
ATE161291T1 (de) 1998-01-15
EP0529493A2 (en) 1993-03-03
DE69223562T2 (de) 1998-06-04
CN1071512A (zh) 1993-04-28
DK0787807T3 (da) 2003-08-11
JP2006180884A (ja) 2006-07-13
GR3026312T3 (en) 1998-06-30

Similar Documents

Publication Publication Date Title
PT787807E (pt) Iniciadores e sondas para a deteccao da hepatite c
ES2179909T3 (es) Cebadores de oligonucleotidos para la amplificacion del acido nucleico del vhc.
ES2196100T3 (es) Cebadores y sondas para la deteccion del vih.
ES2080772T3 (es) Deteccion del virus a de la influenza por reaccion en cadena de polimerasa (pcr) despues de una transcripcion inversa de una zona del gen viral de la hemoaglutinina.
DE602004024034D1 (de) Nukleinsäureamplifikation auf basis von kügelchenemulsion
ES2151002T3 (es) Deteccion del treponema pallidum y haemophilus ducreyi.
EP0593789A4 (en) Method of judging pre-c mutation of hepatitis b virus
KR950701392A (ko) 인체 B형 간염 바이러스에 대한 핵산 증폭 올리고뉴클레오티드 및 프로브(Nucleic Acide Amplification Oligonucleotides and Probes to Human Hepatitis B Birus)
KR930008138A (ko) 특정한 뉴클레오티드 시퀀스를 포함하는 약독화(弱毒化)된 홍역 백신 바이러스 균주와 그의 완벽한 동정 방법
WO1990009457A3 (en) Oligonucleotide primer pairs for sequence independent gene amplification and methods which employ them
DK1284296T3 (da) Fremgangsmåde til påvisning af minority genomer i virus-quasispecies under anvendelse af DNA mikrochips
Neumann-Haefelin et al. Detection and characterization of infectious DNA intermediates of a primate foamy virus
DE69610933D1 (de) Verfahren und reagenzien zur typisierung von hla-genen der klasse i
MXPA02000025A (es) Secuencias y metodos para la deteccion del vih-1.
DE69502402D1 (de) Verfahren zur Amplifizierung und/oder Nachweis einer Nukleinsäuresequenz, Nachweisreagenz und deren Verwendungen
Mohammadi et al. Comparative sensitivity analysis between two methods for species differentiation and interspecies cross contamination in animal cell culture
JP2008079576A (ja) オリゴヌクレオチドセット及びその利用
Nolde et al. Development of an ALU-based realtime PCR assay for the quantitation of genomic (human) DNA
RU93013954A (ru) Способ обнаружения вируса иммунодефицита
YI et al. Development of Multiplex PCR Detection of Blood-borne Viruses by Nucleic Acid Hybridization

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 529493

Country of ref document: ES